K-Stretch, repercusión sobre el bienestar general y la percepción de dolor.

Valorar los cambios reflejados sobre el bienestar general, la percepción de dolor y/o molestias y los niveles de estrés (físico y mental) en una intervención puntual de una sesión de 30 minutos de K-Stretch en los sujetos practicantes.<br /

Percepción de los nuevos graduados de Farmacia sobre la adquisición de competencias frente a los egresados del ciclo formativo

Podeu consultar la Vuitena trobada de professorat de Ciències de la Salut completa a: http://hdl.handle.net/2445/66524Tras la implantación en 2009-10 del nuevo plan de estudios de Farmacia-UB, conviene explorar desde el punto de vista de los nuevos graduados (GF) el papel de las metodologías docentes y de la evaluación en el desarrollo de sus competencias. Para ello, se ha pasado un cuestionario cerrado a la promoción del 2013 y, paralelamente, a egresados del Ciclo formativo (FP) Fabricación de productos farmacéuticos i afines, con el fin de identificar y contrastar qué competencias les parecen haber desarrollado y saber qué factores atribuyen a dicho desarrollo así como posibles carencias. Según las respuestas recibidas (15 FP y 58 GF), ambos grupos coinciden en que los centros contribuyen mucho a adquirir las competencias específicas del área y poco la capacidad comunicativa y ética-sostenibilidad. En las demás, los FP se sienten claramente mejor preparados en competencias que los GF, en particular para el trabajo en equipo. En Farmacia, el método expositivo/lección magistral es el más usado, pero valoran más positivamente el aprendizaje basado en experimentos, casos o problemas. En el Ciclo formativo, lo son el aprendizaje colaborativo y experimentos, igualmente importantes que usados. Entre las actividades realizadas, a ambos grupos les parecen más útiles las prácticas de laboratorio y las externas que el Trabajo de Fin de Grado o el de Síntesis. Test, informe/memoria y trabajo/proyecto son las estrategias evaluativas más empleadas y, además, el examen de desarrollo en FP. Destacan proyectos y prácticas para la adquisición de varias competencias y exposición oral para la capacidad comunicativa y trabajo en equipo..

The impact of digitalization on the strategies of pay TV in Spain

Introduction. The landscape of the audiovisual market has dramatically changed over the last thirty years, and even more so since the implementation of digital terrestrial television throughout Europe. New suppliers of audiovisual content have appeared and a range of pay-per-view and free-to-air services now compete against one another. Methodology. After all the changes, we wonder if there is still space for pay TV and how the strategy of pay TV operators might be developed. To do so, we will analyse current offerings according to three key factors: business models based on revenue and offering, clients, and competitors. Conclusions. After data analysis, we conclude that in spite of the threats to pay television operators, pay TV will be the engine of change, and the willingness to pay will increase. Most of the popular free-to-air contents, will become premium content

Assessing the clinical benefit, safety, and patient-reported outcomes with the use of the PAHcare™ digital platform in pulmonary arterial hypertension: a pilot study

IntroductionDigital health interventions, particularly mobile health platforms, have shown promise in supporting patients with respiratory conditions, but their application in pulmonary arterial hypertension (PAH) remains limited. We aimed to assess the feasibility, acceptability, and potential clinical benefit of the novel PAHcare™ digital platform as a patient-centred intervention for PAH management through a prospective, single-arm, multicenter pilot study conducted on 53 patients diagnosed with PAH who used the platform for 6 months.MethodsThe primary objective was to assess the impact on Health-Related Quality of Life (HRQoL) through questionnaires. Secondary objectives included evaluating clinical outcomes, including disease progression, PAH signs and symptoms, the 6-min walking test, and the patient’s symptom perception. Additionally, we assessed patient satisfaction and engagement with the PAHcare™ platform, interaction with health coaches, retention, costs and healthcare resource utilisation (HCRU), and safety through monitoring device incidents.ResultsMinimal changes in HRQoL and clinical outcomes were observed over 6 months. A noteworthy 92.4% of patients actively used the platform in the first month, maintaining high usage throughout the study. Patient satisfaction was substantial, with more than half of the patients expressing excellence in service quality, willingness to reuse the platform, and fulfilment of their needs. Health coach interaction was high, with 76% of patients initiating contact within the first week. User retention rates were 70%, with prevalent ongoing usage and interaction with healthcare professionals even after the study. In terms of HCRU and costs, the study showed no significant changes in PAH-related hospital admissions, clinical visits, or tests. Finally, the low number of device-related incidents indicated platform safety.ConclusionThis pilot study provides compelling evidence supporting the feasibility and acceptability of the PAHcare™ digital platform to empower patients to manage their disease and significantly enhance their overall experience with PAH

Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension

To assess severity markers and outcomes of patients with systemic sclerosis (SSc) with or without pulmonary arterial hypertension (PAH-SSc/non-PAH-SSc), and the impact of interstitial lung disease (ILD) on PAH-SSc. Non-PAH-SSc patients from the Spanish SSc registry and PAH-SSc patients from the Spanish PAH registry were included. A total of 364 PAH-SSc and 1589 non-PAH-SSc patients were included. PAH-SSc patients had worse NYHA-functional class (NYHA-FC), worse forced vital capacity (FVC) (81.2 ± 20.6% vs 93.6 ± 20.6%, P &lt; 0.001), worse tricuspid annular plane systolic excursion (TAPSE) (17.4 ± 5.2 mm vs 19.9 ± 6.7 mm, P &lt; 0.001), higher incidence of pericardial effusion (30% vs 5.2%, P &lt; 0.001) and similar prevalence of ILD (41.8% vs. 44.9%). In individuals with PAH-SSc, ILD was associated with worse hemodynamics and pulmonary function tests (PFT). Up-front combination therapy was used in 59.8% and 61.7% of patients with and without ILD, respectively. Five-year transplant-free survival rate was 41.1% in PAH-SSc patients and 93.9% in non-PAH-SSc patients (P &lt; 0.001). Global survival of PAH-SSc patients was not affected by ILD regardless its severity. The multivariate survival analysis in PAH-SSc patients confirmed age at diagnosis, worse NYHA-FC, increased PVR, reduced DLCO, and lower management with up-front combination therapy as major risk factors. In conclusion, in PAH-SSc cohort risk of death was greatly increased by clinical, PFT, and hemodynamic factors, whereas it was decreased by up-front combination therapy. Concomitant ILD worsened hemodynamics and PFT in PAH-SSc but not survival regardless of FVC impairment

Guia de pràctica clínica: abordatge del tractament del dolor neuropàtic

Dolor neuropàtic; Epidemiologia; Hospital; Atenció primàriaDolor neuropático; Epidemiología; Hospital; Atención primariaNeuropathic pain; Epidemiology; Hospital; Primary careLa Guia pretén estructurar i consensuar l'atenció dels malalts amb dolor neuropàtic dins del nostre territori. S'especifiquen intervencions preventives i terapèutiques, així com a quin nivell el malalts han de ser atesos en funció de la seva situació clínica i la seva complexitat, els fluxos i metodologia bàsica de derivacions. Es vol potenciar un abordatge transversal i integral del dolor neuropàtic, que abasta l'atenció primària i l'atenció especialitzada hospitalària, i promoure la continuïtat assistencial entre ambdós nivells assistencials, tenint en compte intervencions i criteris compartits, per tal de disminuir la variabilitat de la pràctica clínica i millorar la qualitat i seguretat del pacient

Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension

To assess severity markers and outcomes of patients with systemic sclerosis (SSc) with or without pulmonary arterial hypertension (PAH-SSc/non-PAH-SSc), and the impact of interstitial lung disease (ILD) on PAH-SSc. Non-PAH-SSc patients from the Spanish SSc registry and PAH-SSc patients from the Spanish PAH registry were included. A total of 364 PAH-SSc and 1589 non-PAH-SSc patients were included. PAH-SSc patients had worse NYHA-functional class (NYHA-FC), worse forced vital capacity (FVC) (81.2 +/- 20.6% vs 93.6 +/- 20.6%, P < 0.001), worse tricuspid annular plane systolic excursion (TAPSE) (17.4 +/- 5.2 mm vs 19.9 +/- 6.7 mm, P < 0.001), higher incidence of pericardial effusion (30% vs 5.2%, P < 0.001) and similar prevalence of ILD (41.8% vs. 44.9%). In individuals with PAH-SSc, ILD was associated with worse hemodynamics and pulmonary function tests (PFT). Up-front combination therapy was used in 59.8% and 61.7% of patients with and without ILD, respectively. Five-year transplant-free survival rate was 41.1% in PAH-SSc patients and 93.9% in non-PAH-SSc patients (P < 0.001). Global survival of PAH-SSc patients was not affected by ILD regardless its severity. The multivariate survival analysis in PAH-SSc patients confirmed age at diagnosis, worse NYHA-FC, increased PVR, reduced DLCO, and lower management with up-front combination therapy as major risk factors. In conclusion, in PAH-SSc cohort risk of death was greatly increased by clinical, PFT, and hemodynamic factors, whereas it was decreased by up-front combination therapy. Concomitant ILD worsened hemodynamics and PFT in PAH-SSc but not survival regardless of FVC impairment

Plec : informatiu d'EINA. Núm. 59

Núm. 59 (set./oct. 2007)Editorial: El cartell de la Mercè... aquest any sí! Converses al Vivanda: La renovació d’edifi cis històrics o L’amansiment de l’harpia / Sander Laudy, Thomas Offermans, Tirma Reventós i Cristina Subias. Fet a Eina: Casa de colònies i vivenda a Son Mesquida, Mallorca / Cristina Prats. Het mierennest / Clara Steegmann. En cartell: Exposició, 21 Un segle de cap per avall / Projectes 3 DG, curs 2006-2007. Tipografia de capçalera Muse Gemma Villegas

Structural, electrical and magnetic properties of RE1/3Sr2/3FeO3 compounds (RE = La, Pr, Nd, Eu and Gd)

4 páginas, 3 figuras, 2 tablas.We report results of structural, magnetic and electrical measurements performed on the perovskite RE1/3Sr2/3FeO3 compounds (RE = rare earth). Samples with light RE (La, Pr or Nd) show a metal-insulator-like transition coupled to an antiferromagnetic ordering upon cooling. This transition is believed to be brought about by a charge ordering of Fe3+ and Fe5+ions in the low temperature phase accompanied by the concomitant structural transition. The replacing of light RE by heavy ones (Gd or Eu) gives rise to high-resistivity compounds with no metal-insulator transition. However, the magnetic transition remains at low temperatures. A previous Mössbauer study reports similar behaviour for RE=Eu compound. This suggests that variations in Mössbauer spectra may be of a magnetic origin in light RE compounds and not coming from a full charge disproportionation of Fe4+ as deduced previously.The authors acknowledge financial support from CICyT project FIS08-03951 and DGA (Camrads). V.C. thanks the FPU research grant from MICINN.Peer reviewe